CYTH - Cyclo Therapeutics, Inc.
0.7206
0.010 1.374%
Share volume: 188,267
Last Updated: 03-25-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.01
0.01%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 12-18-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Assets | |||||
| Total Assets | 13.248 M | 7.164 M | 4.718 M | 5.254 M | |
| Current Assets | 12.318 M | 6.570 M | 4.450 M | 3.257 M | |
| Inventories | 254.352 K | 242.530 K | 241.028 K | 236.110 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.247 M | 2.995 M | 1.122 M | 928.010 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 38.332 K | 24.342 K | 22.165 K | 19.988 K | |
| Other Assets | 890.949 K | 569.476 K | 245.552 K | 1.977 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 13.248 M | 7.164 M | 4.718 M | 5.254 M | |
| Total liabilities | 8.491 M | 6.554 M | 9.841 M | 18.727 M | |
| Total current liabilities | 8.468 M | 6.536 M | 9.829 M | 18.720 M | |
| Accounts Payable | 7.457 M | 5.889 M | 6.844 M | 6.522 M | |
| Other liabilities | 22.484 K | 0.000 | 0.000 | 7.143 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 22.484 K | 0.000 | 0.000 | 7.143 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.757 M | 607.152 K | -5.126 M | -13.476 M | |
| Common stock | 88.614 M | 88.807 M | 89.055 M | 89.538 M | |
| Retained earnings | -83.857 M | -88.200 M | -94.181 M | -103.014 M |